This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atrialfibrillation (AF) significantly increases the risk of stroke and heart failure, but is frequently asymptomatic and intermittent; therefore, its timely diagnosis poses challenges. Early detection in selected patients may aid in stroke prevention and mitigate structural heart complications through prompt intervention.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. 1 Approximately 33 million patients worldwide are living with AFib.
cardiac electrophysiologist, performed one of the nations first procedures to control atrialfibrillation (Afib) using a new type of catheter that can deliver two different types of electrical energy or ablation to destroy the damaged part of the heart that is triggering the abnormal heartbeats. 12, 2025 On Feb.
Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrialfibrillation (NVAF) treatment. It's exciting to be part of the evolution of the latest technology into a tangible solution for treating patients. Jennifer Currin, Ph.D.,
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. 1 Among 208 patients included in the Real AF Registry cohort, a total of three PAEs were reported.1 In: AF Symposium.;
In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heart failure, coronary artery disease, vascular disease and atrialfibrillation.
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.
With the integration of Osso VR's immersive technology and the expertise of the ACC, interventionalists will gain access to a state-of-the-art training simulation of the workflow and skills required to successfully perform a left atrial appendage occlusion procedure (LAAO). and globally."
Atrialfibrillation (AFib) cases have also surged, doubling from 28.3 This rise exacerbates the burden on overstretched cardiologists, who are facing a multitude of challenges like clinician shortages, complex workflows, administrative burden, poor patient adherence, health disparities and cost pressure. million in 1990 to 56.7
The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology.
By integrating AI into our products, we enable clinicians to make better use of data, streamline their workflows, and enhance patientcare. Command Center Software Platform: Command Center Software Platform provides a real-time and predictive control system for ongoing patientcare orchestration.
milla1cf Wed, 04/03/2024 - 18:58 April 3, 2024 — GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL. The integration of Caption AI with the Vscan Air SL handheld ultrasound opens an entirely new chapter for cardiac screening.
With the rise of digital health, innovative solutions are emerging that can significantly impact patientcare and recovery while simultaneously addressing health equity. It also facilitates interactions between patients and providers throughout the stroke recovery journey.
In a world where technology reigns supreme, one of the most profound tools in medicine remains the irreplaceable electrocardiogram (ECG). This noninvasive method provides a graphical visualization of millivolt potentials received by electrodes located on the patient’s skin. An abnormal electrocardiogram can mean many things.
Over the past 3 days cardiologists from all over the world met in New Orleans to learn and discuss the developments in technology and patientcare. As ECG Excellence we are proud our CineECG technology was part of this innovation festival. HRS 2023 is a wrap!
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 AtrialFibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
4 Conditions such as Ischemic Heart Disease, AtrialFibrillation, Hypertensive Heart Disease, and Ischemic Stroke make up almost 75% of the deaths due to cardiovascular disease. I’d like to suggest three discrete paths to help provide better access, care, and outcomes for rural America. So what is the way forward?
milla1cf Fri, 05/17/2024 - 18:54 May 17, 2024 — Royal Philips , a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the Heart Rhythm Annual Meeting in Boston (May 16-19).
The support of AI algorithms reduces cardiologists’ workload and enables them to focus on diagnosis, treatment plans, and overall patientcare, rather than manual work. Michael Kühne MD, Head of Clinic AtrialFibrillation at University Hospital Basel in Switzerland.
AccurECG provides automated heart rate measurements, supraventricular and ventricular ectopic beat detection, and automated interpretation for 13 different arrhythmias such as atrialfibrillation, atrial flutter, and ventricular tachycardia.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content